Loading...

5‐aminolaevulinic acid/photo‐dynamic therapy and gefitinib in non‐small cell lung cancer cell lines: a potential strategy to improve gefitinib therapeutic efficacy

OBJECTIVES: Often, non‐small cell lung cancers (NSCLC) respond only poorly to the tyrosine kinase inhibitor (TKI) gefitinib, which targets the epidermal growth factor receptor (EGFR), these poor responders EGFRs lacking activating mutations. In this study, we have attempted to improve TKI response o...

Full description

Saved in:
Bibliographic Details
Published in:Cell Prolif
Main Authors: Postiglione, I., Chiaviello, A., Aloj, S. M., Palumbo, G.
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2013
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6622218/
https://ncbi.nlm.nih.gov/pubmed/23869760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12040
Tags: Add Tag
No Tags, Be the first to tag this record!